Cargando…
ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS
Autores principales: | Cerna, Karin, Duricova, Dana, Lukas, Martin, Machkova, Nadezda, Hruba, Veronika, Lukas, Milan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770921/ http://dx.doi.org/10.1053/j.gastro.2021.12.211 |
Ejemplares similares
-
COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE
por: Spiera, Emily, et al.
Publicado: (2022) -
Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates?
por: Rabizadeh, Soghra, et al.
Publicado: (2021) -
Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?
por: Cerna, Karin, et al.
Publicado: (2023) -
Factors associated with uncontrolled blood pressure in hypertensive Brazilians
por: Araújo, Thayza de Paula, et al.
Publicado: (2022) -
Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases
por: Malíčková, Karin, et al.
Publicado: (2011)